Paola Romagnani

Second star to the right then straight to the morning. You cannot get wrong cause then you find the road yourself....

[Paola Romagnani @PRomagnani]

@ISGDtweets @Tobias_B_Huber Congrats Tobi!!!!

[Hans-Joachim Anders @hjanders_hans]

Now open access in @NDTsocial

Eculizumab for RPGN in children

🧐"All pts with longitudinal follow-up achieved a favorable kidney outcome, contrasting the unsatisfactory prognosis reported in pediatric RPGN"

▶️https://t.co/NKDS4XmDB5

[GlomCon @GlomCon]

Welcome to the post-nephrin era! @PRomagnani , Steve Korbet, @AKronbichler , Mario Rubin, @JeanHouMD , and Neiha Arora break down the MCD-FSGS continuum and treatment options in new diagnosis and refractory disease.

#FSGS #MCD #Podocytes #GlomConHawaii2026 #KidneyImmunology

[Paola Romagnani @PRomagnani]

@KSusztak Fantastic Katalin!

[Katalin Susztak @KSusztak]

Congrats to @IsnardPierre1 and Marco Pontoglio HNF1B integrates signals in a feed-forward loop driving kidney disease progression | Happy to have contributed with Jon Levinsohn @ScienceMagazine https://t.co/uKA0gAhUC0

[Katalin Susztak @KSusztak]

🚨 Our new paper just dropped !!! Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes https://t.co/4WCXVKst5S

[Paola Romagnani @PRomagnani]

@GlassockJ @ministeriosalud @ISNkidneycare Three decades of antihypertensive drugs used worldwide to control blood pressure—yet the rate of “hypertension-related CKD”diagnoses in international registries hasn’t changed. Doesn’t that tell us something?

[ASN Publications @asnpublications]

JASN Editors’ Choice 2025: Piezo1, F-Actin Remodeling, and Podocyte Survival and Regeneration

This study demonstrated that Piezo1 is essential for the survival of podocytes exposed to mechanical stress conditions and for their correct regeneration.

Check out the paper: https://t.co/K7Yd5j8mSD

[Laura Lasagni @LasagniLaura_1]

Our study "Piezo1, F-actin, and podcyte survival and regeneration" has been selected by the ASN editorial team for inclusion in their 2025 JASN-themed highlight edition. @MarEleMelica @PRomagnani @GiuAntonelli12 @AnnaPeired @ElenaLazzeri2 @letiziadechiara @CarolinaConte5

[ASN Publications @asnpublications]

When is Genetic Testing Needed in Glomerular Disease? Check out this perspective in #ASNCJASN https://t.co/CN8rjqhAIJ

[Paola Romagnani @PRomagnani]

@diego_moriconi 😆agree!

[Paola Romagnani @PRomagnani]

In Podocytopathies, histology labels lesions—etiology dictates therapy. Time for an etiology-based classification. Our new review just out in Nat Rev Dis Primers:
https://t.co/gssv3zBYOJ
#Nephrology #PrecisionMedicine #KidneyDisease

[Hans-Joachim Anders @hjanders_hans]

Happy to share our new Nat Rev Dis Primer on

Podocytopathies @DiseasePrimers

including all most recent innovations that impact on management such as anti-nephrin antibodies, ...

@PRomagnani @Tobias_B_Huber @AstridWeins @sydney_tang

https://t.co/E6X3sReqYH

[Hans-Joachim Anders @hjanders_hans]

Everything you need to know about podocyte disorders @DiseasePrimers

@PRomagnani, @Tobias_B_Huber, @AstridWeins, @sydney_tang

https://t.co/E6X3sReqYH

[Paola Romagnani @PRomagnani]

@KSusztak @CircAHA Congrats Katalin!

[Paola Romagnani @PRomagnani]

@WashUNephrology @HumphreysLab @ASNKidney @WashUDeptMed Congrats Ben!

[Hans-Joachim Anders @hjanders_hans]

Now out in @JASN_News
@StefanieSteige6 @PRomagnani

How to Cure Autoimmune GN and podocytopathies

🧐 All autoimmune kidney diseases, no matter what histotype or clinical presentation, benefit from a clone-directed immunotherapy.
▶️https://t.co/RBPMC9vLNx

[Hans-Joachim Anders @hjanders_hans]

Now online in the Journal of the American Society of Nephrology: How to cure glomerulonephritis and podocytopathies? ⁦@PRomagnani⁩ ⁦@StefanieSteige6⁩ https://t.co/RBPMC9vdXZ

[Paola Romagnani @PRomagnani]

Celebrating the Nobel for Tregs brings me back to my youth— to the cells that taught us tolerance, and my father who taught me immunology and the wonder of research. Here’s when we found Treg in the human thymus 23 yrs ago. https://t.co/T3lTBtpJ0l

[Int Society of Nephrology @ISNkidneycare]

🏆 The ISN congratulates Prof. Shimon Sakaguchi, one of our WCN’19 plenary speakers, on being awarded the Nobel Prize in Physiology or Medicine, alongside Mary E. Brunkow and Fred Ramsdell.

His groundbreaking work on peripheral immune tolerance continues to shape scientific understanding and inspire the global kidney community and beyond.

#ISNWCN #NobelPrize #KidneyHealth #GlobalNephrology